In this article
Peptides are short chains of amino acids joined by peptide bonds. Chains of roughly two to fifty amino acids are usually called peptides, while longer, folded chains are called proteins. In the body, most peptides act as chemical messengers that tell cells how to respond.
- A peptide is a short amino acid chain; the cutoff from protein is a convention, around 50 residues.
- Most peptides work by binding a specific receptor, so their effect depends on the receptor, not on whether the molecule is “natural.”
- Several peptides are approved medicines with labels and trial data; many compounds discussed online are not approved for any use.
- Most peptides are broken down by digestion, which is why many are given by injection.
The basic definition
Amino acids are the building blocks the body uses to make proteins. When a small number of them are linked together, the result is a peptide. When many more are linked and the chain folds into a stable three-dimensional shape, it is generally called a protein.
The human body produces thousands of peptides. Insulin helps cells take up glucose, oxytocin is involved in labor and social bonding, and GLP-1 signals fullness after a meal. Because peptides carry such specific messages, drug developers have turned several of them into medicines.
How peptides work
A signaling peptide circulates until it reaches a cell displaying a receptor that fits it. Once the peptide attaches, the receptor triggers a reaction inside the cell. What that reaction is depends on the receptor involved. Some examples:
- Insulin attaches to insulin receptors, prompting cells to clear glucose from the bloodstream.
- GLP-1 acts on receptors in the pancreas, gut and brain. It raises insulin release after eating, slows how fast the stomach empties and dampens appetite. Semaglutide and tirzepatide are modified designs of this message that persist for days rather than minutes.
- Bremelanotide targets melanocortin receptors in the brain, so its effect on sexual desire is central rather than vascular.
- Oxytocin acts through its own receptors, found in the uterus as well as the brain.
Two practical consequences
First, injection is the usual route. Digestive acid and enzymes cleave most peptides before they can be absorbed. Oral versions need special formulation, or they are small molecules built to hit the same receptor and are not peptides at all.
Second, natural peptides tend to be short-lived. Native GLP-1 is cleared within minutes; modified versions are built to bind blood proteins and persist for days. That is why dosing intervals differ so widely between compounds. The peptide half-life guide explains the idea in plain language.
Peptides compared with proteins
| Feature | Peptides | Proteins |
|---|---|---|
| Length | Short: a couple of residues up to about fifty | Longer chains, frequently running to hundreds of residues |
| Structure | Small and mostly flexible | Fold into intricate 3D shapes |
| Usual job | Carrying signals between cells | Building tissue, catalyzing reactions, moving molecules, immune defense |
| Familiar cases | Insulin, GLP-1, oxytocin | Collagen, hemoglobin, antibodies |
The line between them is not strict. Insulin has 51 amino acids and is still called a peptide hormone. A useful rule of thumb is function over length: a peptide usually works as a message, whereas a protein usually works as a piece of cellular equipment.
Peptides that are approved medicines
Peptide drugs are well established, and dozens have regulatory approval. Each comes with a label stating its indication, studied doses, contraindications and side-effect rates from controlled trials.
| Drug | What it is | Approved use |
|---|---|---|
| Human insulin | 51-amino-acid hormone | Diabetes |
| Semaglutide | GLP-1 receptor agonist | Varies by product: type 2 diabetes, long-term weight management, lowering cardiovascular risk |
| Tirzepatide | Dual GIP and GLP-1 receptor agonist | Varies by product: type 2 diabetes, weight management, obstructive sleep apnea |
| Bremelanotide | Melanocortin receptor agonist | Low sexual desire disorder in premenopausal women |
| Tesamorelin | Growth hormone-releasing hormone analog | Abdominal fat excess linked to HIV lipodystrophy |
| Elamipretide | Mitochondria-targeted peptide, studied under the name SS-31 | Barth syndrome |
Related profiles: tesamorelin, SS-31 and PT-141. For a comparison of the newer weight-management agents, see semaglutide vs tirzepatide vs retatrutide.
Research peptides and how they are regulated
Many compounds that circulate in online discussions, including BPC-157, TB-500, GHK-Cu, KPV, MOTS-c, Semax and Epitalon, are not approved medicines. They are sold as research-use-only chemicals, and that label has practical consequences:
- No regulatory review of the product. Nobody has verified that a vial contains the stated compound, at the stated purity, or that it is sterile. A certificate of analysis helps, but only as far as the testing behind it goes.
- Limited human evidence. Much of the supportive data comes from cell and animal studies. A narrative review of BPC-157, the most discussed example, describes how thin the human data are (see References).
- Regulatory attention. FDA maintains a list of bulk substances for compounding that may present significant safety risks, citing concerns such as immune reactions and missing human safety data. Several research peptides have appeared on it, and the status of some has been under review, so check current sources.
- The label is not a loophole. Regulators have indicated that a research-use-only label does not protect a seller who is clearly marketing to people for human use.
The lesson is that “peptide” describes a chemical category, not a level of evidence. An approved peptide medicine and an unapproved research vial can be chemically similar but differ completely in evidence and legal standing. The lesson on research use vs human use covers this distinction in more depth.
Why people study peptides
Interest tends to cluster around a few themes, and the quality of evidence differs sharply between them:
- Weight and metabolic health: the strongest evidence, from large controlled trials of approved GLP-1-based drugs. Newer agents such as retatrutide are investigational (how retatrutide works).
- Tissue repair: compounds like BPC-157 and TB-500, supported mainly by animal data (BPC-157 guide, TB-500 guide).
- Growth hormone axis: tesamorelin is approved for one narrow indication; others are research compounds or discontinued drugs.
- Skin and hair: GHK-Cu has topical research; injected use is less studied (GHK-Cu guide).
- Cognition, sleep and longevity: mostly small studies, cell work and animal models.
To browse compounds by research theme, use peptides by goal.
Safety considerations
Approved peptide drugs have known side-effect profiles. GLP-1-based drugs, for example, commonly cause nausea and other gastrointestinal effects, mostly during dose escalation. Unapproved compounds lack that kind of data. Commonly underestimated risks include:
- Immune reactions to impurities or aggregates.
- Contaminated or mislabeled vials.
- Unit-conversion mistakes when working with lyophilized powder (see how to reconstitute peptides).
- Combining several compounds without anyone tracking the whole picture.
For a structured introduction, the free lesson What is a peptide? and the Signal Library are good next steps, and you can ask follow-up questions in Pulse.
Frequently asked questions
What are peptides in simple terms?
Peptides are small strings of amino acids, the same units that build proteins. Inside the body, most serve as messages that instruct cells.
What do peptides do?
The answer depends on which peptide. Insulin manages blood sugar, GLP-1 lowers appetite and slows digestion, and oxytocin helps start labor. In each case the peptide fits one receptor and produces one kind of response.
What is the difference between peptides and proteins?
Mainly size and role. Peptides are brief chains that generally relay signals. Proteins are longer, adopt elaborate folds, and handle structural and enzymatic tasks.
Are peptides FDA-approved?
Some are. Insulin, semaglutide, tirzepatide, bremelanotide, tesamorelin and elamipretide are approved peptide drugs. Many research peptides, such as BPC-157 and TB-500, have no approved use.
Are peptides the same as steroids?
No. Anabolic steroids are altered forms of testosterone, a lipid hormone. Peptides are amino acid chains that act through different receptors and belong to a different class of compound.
Do peptides have to be injected?
Most do, because digestion breaks them down. A few have oral forms with special formulation, and some skin-directed peptides are applied topically.
References
- McGuire FP et al. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med, 2025 — pubmed.ncbi.nlm.nih.gov
Still have questions? Ask Pulse, Signal IQ’s free AI research assistant, or compare doses in the Peptide Dosage Chart.
Ask PulseEducational content only. Nothing here is medical advice or a recommendation to use any compound. Many peptides discussed are research compounds not approved for human use. Talk to a qualified clinician about your situation. Signal IQ does not sell peptides.



